FRESENIUS KABI is a leader in infusion therapy and clinical nutrition in Europe.
It is focused on the therapy and care of critically and chronically ill patients in both the hospital and home environment. The company develops, manufactures and markets products that offer efficient clinical outcomes combined with a commitment to quality and patient safety. With a corporate philosophy of “Caring for Life” the company’s goal is to improve the patient’s quality of life. At EBME 2017, Fresenius Kabi will be showcasing Agilia Connect, the latest addition to the Agilia range. With integrated WiFi, Agilia Connect works in conjunction with the Vigilant
Software Suite to provide secure and remote system configuration and monitoring, for optimal drug and device usage in all clinical environments.
